Revenue (Tables)

12 Months Ended

Dec. 31, 2019

Revenue

Schedule of reportable segment included under sales category


		2019									2018									2017
(in millions)		U.S.			Int'l			Total			U.S.			Int'l			Total			U.S.			Int'l			Total
Established Pharmaceutical Products —
Key Emerging Markets		$	—		$	3,392		$	3,392		$	—		$	3,363		$	3,363		$	—		$	3,307		$	3,307
Other			—			1,094			1,094			—			1,059			1,059			—			980			980
Total			—			4,486			4,486			—			4,422			4,422			—			4,287			4,287

Nutritionals —
Pediatric Nutritionals			1,879			2,282			4,161			1,843			2,254			4,097			1,777			2,112			3,889
Adult Nutritionals			1,231			2,017			3,248			1,232			1,900			3,132			1,254			1,782			3,036
Total			3,110			4,299			7,409			3,075			4,154			7,229			3,031			3,894			6,925

Diagnostics —
Core Laboratory			1,086			3,570			4,656			985			3,401			4,386			921			3,142			4,063
Molecular			149			293			442			152			332			484			160			303			463
Point of Care			438			123			561			432			121			553			440			110			550
Rapid Diagnostics			1,214			840			2,054			1,148			924			2,072			296			244			540
Total			2,887			4,826			7,713			2,717			4,778			7,495			1,817			3,799			5,616

Medical Devices —
Rhythm Management (a)			1,057			1,087			2,144			1,105			1,093			2,198			1,043			1,089			2,132
Electrophysiology (a)			742			979			1,721			678			883			1,561			596			757			1,353
Heart Failure			574			195			769			467			179			646			491			152			643
Vascular			1,047			1,803			2,850			1,126			1,803			2,929			1,180			1,712			2,892
Structural Heart			616			784			1,400			488			751			1,239			432			651			1,083
Neuromodulation			660			171			831			690			174			864			636			172			808
Diabetes Care			678			1,846			2,524			457			1,476			1,933			332			1,082			1,414
Total			5,374			6,865			12,239			5,011			6,359			11,370			4,710			5,615			10,325

Other (b)			27			30			57			36			26			62			115			122			237

Total		$	11,398		$	20,506		$	31,904		$	10,839		$	19,739		$	30,578		$	9,673		$	17,717		$	27,390

(a)	Insertable Cardiac Monitor (ICM) sales, which had previously been reported in Electrophysiology, are now included in Rhythm Management. Historic periods have been adjusted to reflect this change.

(b)	Diabetes Care sales, which had previously been reported in Other, are now included in the Medical Devices segment. Historic periods have been adjusted to reflect this change.

Schedule of changes in contract liabilities


(in millions)
Contract Liabilities
Balance at January 1, 2018		$	198
Unearned revenue from cash received during the period			304
Revenue recognized related to contract liability balance			(243)
Balance at December 31, 2018			259
Unearned revenue from cash received during the period			411
Revenue recognized related to contract liability balance			(376)
Balance at December 31, 2019		$	294